H40.049
Steroid responder, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
The term 'steroid responder' describes a person who experiences an increase in eye pressure after using steroid medications. This condition can potentially lead to glaucoma, a serious eye disease that can cause vision loss if left untreated. The code H40.049 is used when the specific eye affected isn't specified, categorizing the condition broadly. Recognizing and managing this response is important for protecting eye health, especially in individuals requiring steroids for inflammation or other eye conditions.
Causes & Symptoms
Clinical Causes: Use of steroid eye drops or medications for treating eye inflammation, allergy, or other eye conditions. Genetic predisposition to increased sensitivity to steroids in the eye. Pre-existing eye conditions that may make the eye more prone to pressure changes.
Key Symptoms: Increase in intraocular pressure following steroid use. Mild eye discomfort or pain, particularly if pressure rises significantly. Blurred vision in some cases. No noticeable symptoms if the pressure increase is mild or gradual.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves measuring the eye pressure, also known as intraocular pressure (IOP). An eye care professional might perform a tonometry test before and after starting steroid therapy to monitor changes. Additional eye examinations may be conducted to assess the health of the optic nerve and the drainage angle of the eye. A thorough history of steroid use is crucial for an accurate diagnosis, especially when pressure rises after medication initiation.
Treatment Protocols: Managing a steroid response usually involves a few strategies:
Clinical Advice & FAQs
Billing Guidance
Is H40.049 a billable ICD-10 code?
Yes, H40.049 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H40.049?
Clinical documentation must specify the nature of Steroid responder, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference